Triad of metabolic syndrome, chronic kidney disease, and coronary heart disease with a focus on microalbuminuria: Death by overeating

Journal of the American College of Cardiology

Volumn 57, Issue 23, 2011, Pages 2303-2308

  Gobal, Freij ^a   Deshmukh, Abhishek ^a   Shah, Sudhir ^b   Mehta, Jawahar L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

chronic kidney disease; coronary heart disease; metabolic syndrome; microalbuminuria

Indexed keywords

ALBUMIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PLACEBO; PRAVASTATIN;

ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; EXERCISE; GLOMERULOSCLEROSIS; HEALTH BEHAVIOR; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; MICROALBUMINURIA; MORTALITY; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; WEIGHT REDUCTION;

EID: 79958016904     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.02.027     Document Type: Review

References (81)

1. K. Borch-Johnsen, B. Feldt-Rasmussen, B. Strandgaard, M. Schroll, and J.S. Jensen Urinary albumin excretion An independent predictor of ischemic heart disease Arterioscler Thromb Vasc Biol 19 1999 1992 1997 (Pubitemid 29379934)
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
3. E.S. Ford, W.H. Giles, and W.H. Dietz Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey JAMA 287 2002 356 359 (Pubitemid 34251969)
4. B. Isomaa, M. Henricsson, P. Almgren, T. Tuomi, M.R. Taskinen, and L. Groop The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes Diabetologia 44 2001 1148 1154 (Pubitemid 32842461)
5. J.B. Meigs, P.F. Jacques, J. Selhub Framingham Offspring Study Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham Offspring Study Diabetes Care 24 2001 1403 1410 (Pubitemid 33716428)
6. L. Palaniappan, M. Carnethon, and S.P. Fortmann Association between microalbuminuria and the metabolic syndrome: NHANES III Am J Hypertens 16 2003 952 958 (Pubitemid 37315495)
7. A.M. Hodge, G.K. Dowse, and P.Z. Zimmet Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus Diabet Med 13 1996 441 449 (Pubitemid 26173430)
8. X. Jiang, S.R. Srinivasan, B. Radhakrishnamurthy, E.R. Dalferes, W. Bao Jr., and G.S. Berenson Microalbuminuria in young adults related to blood pressure in a biracial (black-white) population The Bogalusa Heart Study Am J Hypertens 7 1994 794 800 (Pubitemid 24316029)
9. S.R. Srinivasan, L. Myers, and G.S. Berenson Risk variables of insulin resistance syndrome in African-American and Caucasian young adults with microalbuminuria Am J Hypertens 13 2000 1274 1279
10. H.C. Gerstein, J.F. Mann, Q. Yi HOPE Study Investigators Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 286 2001 421 426 (Pubitemid 32681484)
11. K.G.M.M. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications Diabet Med 15 1998 539 553
12. L. Mykknen, D.J. Zaccaro, L.E. Wagenknecht, D.C. Robbins, M. Gabriel, and S.M. Haffner Microalbuminuria is associated with insulin resistance in nondiabetic subjects The Insulin Resistance Atheroscleorosis Study Diabetes 7 1998 793 800 (Pubitemid 28201810)
13. W.K. Keane Nephrology forum: lipids and the kidney Kidney Int 6 1994 910 920
14. T.V. Perneger, F.J. Nieto, P.K. Whelton, M.J. Klag, G.W. Comstock, and M. Szklo A prospective study of blood pressure and serum creatinine Results from the "Clue" Study and the ARIC Study JAMA 269 1993 488 493 (Pubitemid 23027504)
15. B. Isomaa, P. Almgren, and T. Tuomi Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 2001 683 689 (Pubitemid 32893993)
16. J. Kuusisto, L. Mykknen, K. Pyrl, and M. Laakso Hyperinsulinemic microalbuminuria A new risk indicator for coronary heart disease Circulation 91 1995 831 837
17. V.J. Dzau, and M.E. Safar Large conduit arteries in hypertension: role of the vascular renin- angiotensin Circulation 77 1988 947 954
18. K. Shinozaki, K. Ayajiki, Y. Nishio, T. Sugaya, K. Atsunori, and T. Okamura Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance Hypertension 43 2004 255 262 (Pubitemid 38174184)
19. P.K. Mehta, and K.K. Griendling Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Am J Physiol Cell Physiol 292 2007 C82 C97
20. N. Anilkumar, R. Weber, M. Zhang, A. Brewer, and A.M. Shah Nox4 and nox2 NADPH oxidases mediate distinct cellular redox signaling response to agonist stimulation Arterioscler Thromb Vasc Biol 28 2008 1347 1354
21. J.L. Mehta Oxidized or native low-density lipoprotein cholesterol: which is more important in atherogenesis? J Am Coll Cardiol 48 2006 980 982
22. E. Maggi, R. Bellazzi, and F. Falaschi Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? Kidney Int 45 1994 876 883 (Pubitemid 24094502)
23. P. Holvoet, A. Mertens, and P. Verhamme Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease Arterioscler Thromb Vasc Biol 21 2001 844 848 (Pubitemid 32448777)
24. D.L. Lawson, J.L. Mehta, W.W. Nichols, P. Mehta, and W.H. Donnelly Superoxide radical-mediated endothelial injury and vasoconstriction of rat thoracic aortic rings J Lab Clin Med 115 1990 541 548 (Pubitemid 20184433)
25. T. Mnzel, T. Heitzer, and D.G. Harrison The physiology and pathophysiology of the nitric oxide/superoxide system Herz 22 1997 158 172 (Pubitemid 27282855)
26. G. Ambrosio, P. Golino, and I. Pascucci Modulation of platelet function by reactive oxygen metabolites Am J Physiol 267 1994 H308 H318
27. L. Cominacini, A.F. Pasini, and U. Garbin The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells J Am Coll Cardiol 41 2003 499 507 (Pubitemid 36164510)
28. J.L. Mehta, J. Chen, P.L. Hermonat, F. Romeo, and G. Novelli Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders Cardiovasc Res 69 2006 36 45 (Pubitemid 41814809)
29. D.Y. Li, Y.C. Zhang, M.I. Philips, T. Sawamura, and J.L. Mehta Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation Circ Res 84 1999 1043 1049 (Pubitemid 29227683)
30. D. Li, T. Saldeen, F. Romeo, and J.L. Mehta Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappa B Circulation 102 2000 1970 1976
31. F.J. Byfield, S. Tikku, G.H. Rothblat, K.J. Gooch, and I. Levitan OxLDL increases endothelial stiffness, force generation, and network formation J Lipid Res 47 2006 715 723
32. C.R. Ban, and S.M. Twigg Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers Vasc Health Risk Manag 4 2008 575 596 (Pubitemid 352037917)
33. C. Hu, A. Dandapat, and L. Sun Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion Hypertension 52 2008 556 562
34. C. Hu, B.Y. Kang, J. Megyesi, G.P. Kaushal, R.L. Safirstein, and J.L. Mehta Deletion of LOX-1 attenuates renal injury following angiotensin II infusion Kidney Int 76 2009 521 527
35. J. Chen, and J.L. Mehta Interaction of oxidized low-density lipoprotein and the renin-angiotensin system in coronary artery disease Curr Hypertens Rep 8 2006 139 143 (Pubitemid 43796691)
36. G. Milan, M. Granzotto, and A. Scarda Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss Obes Res 10 2002 1095 1103 (Pubitemid 135686650)
37. R.J. Sidell, M.A. Cole, N.J. Draper, M. Desrois, R.E. Buckingham, and K. Clarke Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the Zucker fatty rat heart Diabetes 51 2002 1110 1117 (Pubitemid 34438357)
38. A.M. Karkar, J.C. Smith, and C.D. Pusey Prevention and treatment of experimental cresentic glomerulonephritis by blocking tumour necrosis factor-alpha Nephrol Dial Transplant 16 2001 518 524 (Pubitemid 32229283)
39. J.F. Navarro, and C. Mora Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy Diabetes Care 22 1999 1006 1008 (Pubitemid 29241066)
40. M. Nannipieri, G. Penno, and L. Rizzo Transcapillary escape rate of albumin in type II diabetic patients The relationship with microalbuminuria and hypertension Diabetes Care 20 1997 1019 1026 (Pubitemid 27224957)
41. J. Chen, P. Muntner, and L.L. Hamm Insulin resistance and risk of chronic kidney disease in nondiabetic US adults J Am Soc Nephrol 14 2003 469 477 (Pubitemid 36150872)
42. J. Chen, P. Muntner, and L.L. Hamm The metabolic syndrome and chronic kidney disease in U.S. adults Ann Intern Med 140 2004 167 174
43. M. Kurella, J.C. Lo, and M. Glenn Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults J Am Soc Nephrol 16 2005 2134 2140 (Pubitemid 41716445)
44. J.R. Weisinger, R.L. Kempson, F.L. Eldridge, and R.S. Swenson The nephrotic syndrome: a complication of massive obesity Ann Intern Med 81 1974 440 447
45. R.R. Verani Obesity-associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia Am J Kidney Dis 20 1992 629 634 (Pubitemid 23031716)
46. K. Iseki, Y. Ikemiya, K. Kinjo, T. Inoue, C. Iseki, and S. Takishita Body mass index and the risk of development of end-stage renal disease in a screened cohort Kidney Int 65 2004 1870 1876 (Pubitemid 38591038)
47. N. Kambham, G.S. Markowitz, A.M. Valeri, J. Lin, and V.D. D'Agati Obesity-related glomerulopathy: an emerging epidemic Kidney Int 59 2001 1498 1509 (Pubitemid 32281241)
48. M. Praga, E. Hernandez, and E. Morales Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis Nephrol Dial Transplant 16 2001 1790 1798 (Pubitemid 32821410)
49. J.R. Henegar, S.A. Bigler, L.K. Henegar, S.C. Tyagi, and J.E. Hall Functional structural changes in the kidney in the early stages of obesity J Am Soc Nephrol 12 2001 1211 1217 (Pubitemid 32472634)
50. J.E. Hall, J.R. Henegar, and T.M. Dwyer Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther 11 2004 41 54 (Pubitemid 38174673)
51. M. Praga Obesitya neglected culprit in renal disease Nephrol Dial Transplant 17 2002 1157 1159 (Pubitemid 34812055)
52. A. Chagnac, T. Weinstein, A. Korzets, E. Ramadan, J. Hirsch, and U. Gafter Glomerular hemodynamics in severe obesity Am J Physiol Renal Physiol 278 2000 F817 F822
53. R.D. Adelman, I.G. Restaino, U.S. Alon, and D.L. Blowey Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents J Pediatr 138 2001 481 485 (Pubitemid 32319719)
54. M. Manttari, E. Tiula, T. Alikoski, and V. Manninen Effects of hypertension and dyslipidemia on the decline in renal function Hypertension 26 1995 670 675
55. L.F. Fried, T.J. Orchard, and B.L. Kasiske Effect of lipid reduction on the progression of renal disease: a meta-analysis Kidney Int 59 2001 260 269 (Pubitemid 32055234)
56. L.G. Hunsicker, S. Adler, and A. Caggiula Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study Kidney Int 51 1997 1908 1919 (Pubitemid 27252762)
57. P. Muntner, J. Coresh, J.C. Smith, J. Eckfeldt, and M.J. Klag Plasma lipids and risk of developing renal dysfunction: the Atherosclerosis Risk in Communities Study Kidney Int 58 2000 293 301 (Pubitemid 30429874)
58. J.D. McGarry Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes Diabetes 51 2002 7 18
59. A. Kamijo, K. Kimura, and T. Sugaya Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage Kidney Int 62 2002 1628 1637 (Pubitemid 35286270)
60. J. Lindstrom, A. Louheranta, and M. Mannelin The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity Diabetes Care 26 2003 3230 3236 (Pubitemid 37466880)
61. C.K. Abrass, and A.K. Berfield Phenotypic modulation of rat glomerular visceral epithelial cells by culture substratum J Am Soc Nephrol 5 1995 1591 1599
62. A.M. Sharma Is there a rationale for angiotensin blockade in the management of obesity and hypertension? Hypertension 44 2004 12 19 (Pubitemid 38823478)
63. R. Sukhija, Z. Bursac, and P. Kakar Effect of statins on the development of renal dysfunction Am J Cardiol 101 2008 975 979
64. W.C. Knowler, E. Barrett-Connor, S.E. Fowler Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Eng J Med 346 2002 393 403 (Pubitemid 34437694)
65. R.J. Jarrett, G.C. Viberti, A. Argyropoulos, R.D. Hill, U. Mahmud, and T.J. Murrells Microalbuminuria predicts mortality in non-insulin-dependent diabetics Diabet Med 1 1984 17 19 (Pubitemid 14004823)
66. M.F. Yuyun, K.T. Khaw, and R. Luben A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population: the EPIC-Norfolk study Am J Epidemiol 159 2004 284 293 (Pubitemid 38141658)
67. W.J. Gorgels, Y. van der Graaf, and P. Hjemdahl Urinary excretions of high molecular weight beta-thromboglobulin and albumin are independently associated with coronary heart disease in women: a nested case-control study of middle-aged women in the Diagnostisch Onderzoek Mammacarcinoom (DOM) Cohort, Utrecht, Netherlands Am J Epidemiol 142 1995 1157 1164
68. J.S. Jensen Renal and systemic transvascular albumin leakage in severe atherosclerosis Arterioscler Thromb Vasc Biol 15 1995 1324 1329
69. C.D. Stehouwer, J.J. Nauta, G.C. Zeldenrust, W.H. Hackeng, A.J. Donker, and G.J. den Ottolander Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus Lancet 340 1992 319 323
70. A. Festa, R. D'Agostino, G. Howard, L. Mykkanen, R.P. Tracy, and S.M. Haffner Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the Insulin Resistance Atherosclerosis Study Kidney Int 58 2000 1703 1710
71. P.W. Wilson, R.B. D'Agostino, D. Levy, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847 (Pubitemid 28213628)
72. T.F. Thomsen, M. Davidsen, H. Ibsen, T. Jørgensen, G. Jensen, and K. Borch-Johnsen A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials: PRECARD and the Copenhagen Risk Score J Cardiovasc Risk 8 2001 291 297 (Pubitemid 33010689)
73. J.S. Yudkin, and N. Chaturvedi Developing risk stratification charts for diabetic and nondiabetic subjects Diabet Med 16 1999 219 227
74. R. Sukhija, W.S. Aronow, and P. Kakar Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus Am J Cardiol 98 2006 279 281 (Pubitemid 44062430)
75. C.E. Mogensen Practice guidelines for chronic kidney disease Ann Intern Med 140 2004 933 934
76. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
77. The HOPE Study Investigators Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy Heart Outcomes Prevention Evaluation Study Investigators Lancet 355 2000 253 259
78. P. Gaede, P. Vedel, N. Larsen, G.V. Jensen, H.H. Parving, and O. Pedersen Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 348 2003 383 393 (Pubitemid 36159355)
79. F.W. Asselbergs, G.F. Diercks, H.L. Hillege PREVEND IT Investigators Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria Circulation 110 2004 2809 2816 (Pubitemid 39473602)
80. H. Ibsen, K. Wachtell, M.H. Olsen LIFE Substudy Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy J Hypertens 22 2004 1805 1811 (Pubitemid 39141974)
81. H. Ibsen, M.H. Olsen, and K. Wachtell Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan Intervention for Endpoint Reduction in Hypertension study Hypertension 45 2005 198 202 (Pubitemid 40179960)